PL356640A1 - Leczenie zakażeń wirusowych za pomocą LEVOVIRIN - Google Patents

Leczenie zakażeń wirusowych za pomocą LEVOVIRIN

Info

Publication number
PL356640A1
PL356640A1 PL00356640A PL35664000A PL356640A1 PL 356640 A1 PL356640 A1 PL 356640A1 PL 00356640 A PL00356640 A PL 00356640A PL 35664000 A PL35664000 A PL 35664000A PL 356640 A1 PL356640 A1 PL 356640A1
Authority
PL
Poland
Prior art keywords
levovirintm
treatment
viral infections
infections
viral
Prior art date
Application number
PL00356640A
Other languages
English (en)
Inventor
Robert Tam
Original Assignee
Icn Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Icn Pharmaceuticals, Inc. filed Critical Icn Pharmaceuticals, Inc.
Publication of PL356640A1 publication Critical patent/PL356640A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/044—Pyrrole radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/056—Triazole or tetrazole radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
PL00356640A 1999-12-23 2000-12-15 Leczenie zakażeń wirusowych za pomocą LEVOVIRIN PL356640A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/471,513 US6518253B1 (en) 1999-11-19 1999-12-23 Treatment of viral infections using the L-isomer of ribavirin

Publications (1)

Publication Number Publication Date
PL356640A1 true PL356640A1 (pl) 2004-06-28

Family

ID=23871906

Family Applications (1)

Application Number Title Priority Date Filing Date
PL00356640A PL356640A1 (pl) 1999-12-23 2000-12-15 Leczenie zakażeń wirusowych za pomocą LEVOVIRIN

Country Status (22)

Country Link
US (2) US6518253B1 (pl)
EP (1) EP1246832A1 (pl)
JP (1) JP2003518134A (pl)
KR (1) KR20030016213A (pl)
CN (1) CN1409721A (pl)
AU (1) AU2281601A (pl)
BR (1) BR0016163A (pl)
CA (1) CA2384110A1 (pl)
CZ (1) CZ2002968A3 (pl)
HK (1) HK1050011A1 (pl)
HR (1) HRP20020486A2 (pl)
HU (1) HUP0400500A2 (pl)
IL (1) IL148510A0 (pl)
MX (1) MXPA02006259A (pl)
NO (1) NO20022816D0 (pl)
PL (1) PL356640A1 (pl)
RU (1) RU2002112248A (pl)
SI (1) SI21042A (pl)
SK (1) SK6252002A3 (pl)
WO (1) WO2001046212A1 (pl)
YU (1) YU47702A (pl)
ZA (1) ZA200202739B (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7638496B2 (en) 2000-02-15 2009-12-29 Valeant Pharmaceuticals North America Nucleoside analogs with carboxamidine modified monocyclic base
CN101862345B (zh) 2000-10-18 2014-06-04 吉利德制药有限责任公司 用于治疗病毒感染和异常细胞增殖的修饰核苷类化合物
JP2005539032A (ja) * 2002-08-12 2005-12-22 エフ．ホフマン−ラ　ロシュ　アーゲー リボフラノースの製造方法
CA2508656A1 (en) * 2002-12-10 2004-06-24 F.Hoffmann-La Roche Ag Antiviral nucleoside derivatives
CN100347184C (zh) * 2003-01-07 2007-11-07 凯敏制药欧洲股份有限公司 可用于治疗由黄病毒科病毒如丙型肝炎及牛病毒性腹泻病毒引起的感染的双环糖类化合物
US6930093B2 (en) * 2003-07-10 2005-08-16 Valeant Research & Development Use of ribofuranose derivatives against inflammatory bowel diseases
US20050009848A1 (en) * 2003-07-10 2005-01-13 Icn Pharmaceuticals Switzerland Ltd. Use of antivirals against inflammatory bowel diseases
US20050182252A1 (en) 2004-02-13 2005-08-18 Reddy K. R. Novel 2'-C-methyl nucleoside derivatives
US20140010783A1 (en) * 2012-07-06 2014-01-09 Hoffmann-La Roche Inc. Antiviral compounds
AU2015217221A1 (en) 2014-02-13 2016-08-11 Ligand Pharmaceuticals, Inc. Prodrug compounds and their uses
WO2016003812A1 (en) 2014-07-02 2016-01-07 Ligand Pharmaceuticals, Inc. Prodrug compounds and uses therof
AU2019207625A1 (en) 2018-01-09 2020-07-30 Ligand Pharmaceuticals, Inc. Acetal compounds and therapeutic uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5767097A (en) * 1996-01-23 1998-06-16 Icn Pharmaceuticals, Inc. Specific modulation of Th1/Th2 cytokine expression by ribavirin in activated T-lymphocytes
US6150337A (en) * 1996-01-23 2000-11-21 Icn Pharmaceuticals, Inc. Specific modulation of Th1/Th2 cytokine expression by Ribavirin in activated T-lymphocytes
EP1027359B9 (en) * 1996-10-16 2003-09-17 Ribapharm, Inc. Monocyclic l-nucleosides, analogs and uses thereof

Also Published As

Publication number Publication date
IL148510A0 (en) 2002-09-12
HRP20020486A2 (en) 2004-08-31
SK6252002A3 (en) 2003-02-04
KR20030016213A (ko) 2003-02-26
EP1246832A1 (en) 2002-10-09
AU2281601A (en) 2001-07-03
JP2003518134A (ja) 2003-06-03
US20030092644A1 (en) 2003-05-15
HUP0400500A2 (hu) 2004-07-28
ZA200202739B (en) 2003-09-23
SI21042A (sl) 2003-04-30
NO20022816L (no) 2002-06-13
YU47702A (sh) 2005-11-28
CN1409721A (zh) 2003-04-09
BR0016163A (pt) 2002-08-13
RU2002112248A (ru) 2004-01-20
US6518253B1 (en) 2003-02-11
CZ2002968A3 (cs) 2003-10-15
NO20022816D0 (no) 2002-06-13
HK1050011A1 (zh) 2003-06-06
WO2001046212A1 (en) 2001-06-28
MXPA02006259A (es) 2003-01-28
CA2384110A1 (en) 2001-06-28

Similar Documents

Publication Publication Date Title
AP2001002301A0 (en) Inhibition of viral infection using monovalentantigen-binding proteins
IL129352A0 (en) Benzimidazole-2- carbamates for the treatment of viral infections and cancer
PH12000003381B1 (en) Enzyme treatment for infection
IL139002A0 (en) Compositions for the treatment of hiv and other viral infections
PL376454A1 (pl) Pochodne 1-acylo-pirolidynowe do leczenia zakażeńwirusowych
AU1167602A (en) Methods of therapy for hiv infection
AU2001269704A1 (en) Oxazinoquinolones useful for the treatment of viral infections
PL356640A1 (pl) Leczenie zakażeń wirusowych za pomocą LEVOVIRIN
GB9925136D0 (en) Novel treatment
PL349347A1 (en) Novel treatment
AP2002002432A0 (en) Treatment of viral infections
NZ513686A (en) Treatment of trauma
PT1220858E (pt) Oxazinoquinolonas uteis para o tratamento de infeccoes virais
HUP0105310A3 (en) Use of phosphororganic compounds for the prophylactic and therapeutical treatment of infections
AU3524700A (en) Prevention and treatment of viral infections
GB2362827B (en) Pharmaceutical preparation for treating viral infections
IL143795A0 (en) Use of 3-isoxazolidinones and hydroxylamic acids for the treatment of infections
GB0023198D0 (en) Treatment of DNA viral infections
SI1220858T1 (en) Oxazinoquinolones useful for the treatment of viral infections
GB0023200D0 (en) Synergistic treatment of DNA viral infections
EP1210088A4 (en) 2-AMINOBENZOXAZINONE FOR TREATING THE HERPES SIMPLEX VIRUS
AU4024400A (en) Composition and methods for the treatment of cancer and viral infections
EP1165060A4 (en) PROCESSING OF BILARIAL CALCULATIONS
AU3720600A (en) Application of dna vectors for the treatment of viral infection
ZA993346B (en) The treatment of viral infections.

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)